421.11
前日終値:
$382.97
開ける:
$444.5
24時間の取引高:
606.84K
Relative Volume:
2.48
時価総額:
$5.65B
収益:
$2.53B
当期純損益:
$265.24M
株価収益率:
22.93
EPS:
18.3669
ネットキャッシュフロー:
$325.48M
1週間 パフォーマンス:
+9.49%
1か月 パフォーマンス:
+12.63%
6か月 パフォーマンス:
-3.55%
1年 パフォーマンス:
-22.98%
Chemed Corp Stock (CHE) Company Profile
Compare CHE vs HCA, THC, FMS, ENSG, UHS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CHE
Chemed Corp
|
421.11 | 5.14B | 2.53B | 265.24M | 325.48M | 18.37 |
|
HCA
Hca Healthcare Inc
|
432.46 | 105.98B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
180.81 | 16.50B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.77 | 12.43B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
189.16 | 11.06B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
174.35 | 11.06B | 17.36B | 1.51B | 849.25M | 23.15 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | ダウングレード | Jefferies | Buy → Hold |
| 2025-09-02 | アップグレード | Jefferies | Hold → Buy |
| 2025-07-25 | 開始されました | Jefferies | Hold |
| 2020-03-11 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | 繰り返されました | BofA/Merrill | Buy |
| 2018-10-12 | 開始されました | BofA/Merrill | Buy |
| 2017-08-28 | 開始されました | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | 繰り返されました | Oppenheimer | Outperform |
| 2015-10-26 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | 繰り返されました | Oppenheimer | Outperform |
| 2015-07-27 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | 繰り返されました | Oppenheimer | Outperform |
| 2014-09-23 | 繰り返されました | Oppenheimer | Outperform |
| 2014-06-10 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | 繰り返されました | Oppenheimer | Outperform |
| 2013-09-10 | 繰り返されました | Deutsche Bank | Hold |
| 2011-03-04 | 繰り返されました | Barclays Capital | Underweight |
| 2011-02-17 | 繰り返されました | Oppenheimer | Outperform |
| 2011-02-17 | 繰り返されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Chemed Corp (CHE) 最新ニュース
Chemed Stock Jumps 11% on Q1 Beat, VITAS Hospice Strength and Raised 2026 Outlook - inkl
CHE: VITAS outperformed in Q1 2026, driving raised guidance, while Roto-Rooter navigated headwinds - TradingView
Full Transcript: Chemed Q1 2026 Earnings Call - Benzinga
CHE: VITAS outperformed expectations and guidance was raised, while Roto-Rooter saw mixed results and higher costs - TradingView
Chemed Q1 2026 presentation reveals Roto-Rooter divestiture plans - Investing.com
Transcript : Chemed Corporation, Q1 2026 Earnings Call, Apr 24, 2026 - marketscreener.com
Earnings call transcript: Chemed Q1 2026 earnings exceed forecasts, stock surges - Investing.com Canada
Sensient Technologies, Chemed, AMD, Arm And Other Big Stocks Moving Higher On Friday - Benzinga
Chemed (NYSE:CHE) Shares Gap Up After Strong Earnings - MarketBeat
Copeland Capital Management LLC Sells 8,815 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Sold by State of Alaska Department of Revenue - MarketBeat
Chemed: Q1 Earnings Snapshot - theheraldreview.com
CHE: 2025 revenue grew 4.1% to $2.53B, but adjusted EBITDA and net income declined - TradingView
Chemed (NYSE:CHE) Posts Earnings Results, Beats Estimates By $0.35 EPS - MarketBeat
Chemed Corp (NYSE:CHE) Soars on Q1 Beat and Raised Full-Year Guidance - ChartMill
Chemed (NYSE:CHE) Issues FY 2026 Earnings Guidance - MarketBeat
CHE: VITAS outperformed, boosting guidance, while Roto-Rooter faced margin pressure and revenue decline - TradingView
Chemed Corp (CHE) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Chemed reports Q1 2026: Revenue $657.5M, GAAP EPS $4.84, Adjusted EPS $5.65 - TradingView
Chemed (NYSE: CHE) raises 2026 EPS guidance as VITAS outperforms, Roto-Rooter margins ease - Stock Titan
Chemed Reports First-Quarter 2026 Results - Bluefield Daily Telegraph
Chemed earnings on deck as hospice, plumbing units face tests - Investing.com UK
M&T Bank Corp Raises Stock Holdings in Chemed Corporation $CHE - MarketBeat
Chemed Corp. Q1 2026 Earnings Report: Forecast & Analyst SentimentNews and Statistics - IndexBox
CHE (Chemed Corp) reports Q4 2025 EPS miss and 4.1 percent year over year revenue growth, stock edges higher.EBITDA Margin - Cổng thông tin điện tử Tỉnh Sơn La
Evergreen Capital Management LLC Trims Position in Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Sold by Boston Trust Walden Corp - MarketBeat
Chemed Corporation (NYSE:CHE) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
What could accelerate Chemed (CHE) stock growth (At Lows) 2026-04-20Price Momentum - UBND thành phố Hải Phòng
Chemed Corp (CHE) Stock Analysis: Evaluating a 15% Growth Potential Amidst Stable Healthcare Services - DirectorsTalk Interviews
Chemed Corp stock (US1638321034): Why Google Discover changes matter more now - AD HOC NEWS
Chemed Corp stock (US1638321034): Why does its hospice dominance matter more for U.S. investors now? - AD HOC NEWS
Responsive Playbooks and the CHE Inflection - Stock Traders Daily
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Chemed Corporation $CHE Shares Sold by Tudor Investment Corp ET AL - MarketBeat
Chemed (CHE) to Release Earnings on Thursday - MarketBeat
Chemed (CHE) Stock: Risk Exposure (Slow Grind) 2026-04-15Continuation Pattern - Cổng thông tin điện tử tỉnh Tây Ninh
CHE Stock Price, Quote & Chart | CHEMED CORP (NYSE:CHE) - ChartMill
Chemed secures $450 million revolving credit facility By Investing.com - Investing.com Canada
Chemed Renews $450 Million Five-Year Revolving Credit Facility Led by JPMorgan - TradingView
Chemed (NYSE: CHE) secures five-year $450M revolving credit facility - Stock Titan
Chemed secures $450 million revolving credit facility - Investing.com
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement - Yahoo Finance
Chemed Corp (CHE) Stock Analysis: Exploring A 14.81% Upside Potential - DirectorsTalk Interviews
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Smith Salley Wealth Management's Chemed Corp(CHE) Holding History - GuruFocus
Oak Thistle LLC Sells 4,113 Shares of Chemed Corporation $CHE - MarketBeat
Clerical correction: Chemed (NYSE: CHE) restates shares outstanding for 2026 meeting - Stock Titan
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed Corp (CHE) Stock forecasts - Yahoo Finance UK
How expensive is Chemed (CHE) Stock now | Price at $394.69, Up 1.47%Intraday Trading - UBND thành phố Hải Phòng
Chemed Corp (CHE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):